Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Virus”

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03031912
What this trial is testing

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola

Who this might be right for
Ebola
Canadian Immunization Research Network 251
Early research (Phase 1)Study completedNCT02326194
What this trial is testing

A Phase I Clinical Trial to Evaluate the Ebola Adenovirus Vector Vaccine (Ad5-EBOV) in Healthy Adults.

Who this might be right for
Ebola Virus Disease
Jiangsu Province Centers for Disease Control and Prevention 120
Testing effectiveness (Phase 2)Active Not RecruitingNCT06803342
What this trial is testing

A Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Sudan Ebolavirus Vaccine in Healthy Adults

Who this might be right for
Ebola Sudan Virus Disease
Albert B. Sabin Vaccine Institute 200
Early research (Phase 1)Study completedNCT03428347
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Medicinal Product for Emergency Prevention of Ebola

Who this might be right for
Healthy
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Early research (Phase 1)UnknownNCT05301504
What this trial is testing

A Study in Tanzania of a New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 76
Early research (Phase 1)Study completedNCT02283099
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine (rVSVΔG-ZEBOV-GP)

Who this might be right for
Hemorrhagic Fever, Ebola
Universitätsklinikum Hamburg-Eppendorf 30
Large-scale testing (Phase 3)Looking for participantsNCT06126822
What this trial is testing

Safety and Immunogenicity of Ervebo® and Zabdeno® Booster Vaccines Against Ebola Virus Following Previous Vaccination with the Zabdeno/Mvabea® or Ervebo® Vaccine Schedules in DRC

Who this might be right for
Ebola Virus Disease
Institute of Tropical Medicine, Belgium 624
Testing effectiveness (Phase 2)Study completedNCT02363322
What this trial is testing

Putative Investigational Therapeutics in the Treatment of Patients With Known Ebola Infection

Who this might be right for
Ebola Virus Infection
National Institute of Allergy and Infectious Diseases (NIAID) 72
Not applicableStudy completedNCT03820739
What this trial is testing

EBOVAC-Salone Extension

Who this might be right for
Ebola Virus Disease
London School of Hygiene and Tropical Medicine 653
Testing effectiveness (Phase 2)WithdrawnNCT04268966
What this trial is testing

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

Who this might be right for
Ebola Virus Disease
Jazz Pharmaceuticals
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Early research (Phase 1)WithdrawnNCT02389192
What this trial is testing

Safety and Pharmacokinetics of a Single ZMappTM Administration in Healthy Adult Volunteers

Who this might be right for
Healthy
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)Study completedNCT02543567
What this trial is testing

Evaluate A Range of Dose Levels of Ad26.ZEBOV and MVA-BN-Filo in Healthy Adult Participants

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 525
Large-scale testing (Phase 3)Study completedNCT03719586
What this trial is testing

Investigational Therapeutics for the Treatment of People With Ebola Virus Disease

Who this might be right for
Ebola Virus
National Institute of Allergy and Infectious Diseases (NIAID) 681
Early research (Phase 1)Ended earlyNCT01518881
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 24
Early research (Phase 1)Study completedNCT00072605
What this trial is testing

Experimental Ebola Vaccine Trial

Who this might be right for
Hemorrhagic Fever, EbolaHealthy
National Institute of Allergy and Infectious Diseases (NIAID) 27
Early research (Phase 1)Study completedNCT02401373
What this trial is testing

A Phase I Trial to Evaluate Ad5-EBOV in Healthy Adult Africans in China.

Who this might be right for
Ebola Virus Disease
First Affiliated Hospital of Zhejiang University 61
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Early research (Phase 1)Study completedNCT02485912
What this trial is testing

Evaluation of a New Ebola Vaccine Using a Short-interval Prime-boost Vaccination

Who this might be right for
Ebola Virus Disease
University of Oxford 40
Early research (Phase 1)Study completedNCT05079750
What this trial is testing

A New Vaccine Against Two Types of Ebola

Who this might be right for
Ebola
University of Oxford 26
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation